Clinical Trials Browser

Phase 1 × Liver Diseases × avelumab × Clear all

NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Phase 1 Completed

22 enrolled 25 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms